Mohindru Mani Insider Trades

Insider Trading History

Track insider trading activity for Mohindru Mani. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cardiff Oncology
Cardiff Oncology CRDF
Chief Executive Officer
Holding Value $1.21M 968,766 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 600,000 shares
$1.62
$1.25
Cardiff Oncology
Cardiff Oncology CRDF
Interim CEO
Holding Value $461k 368,766 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 200,000 shares
$1.56
$1.25
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $211k 168,766 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 40,565 shares
$3.16
$1.25
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $120k 38,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 38,000 shares
$2.82
$3.15
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $160k 128,201 shares
Last Trade
Jun 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.2k 29,700 shares
$2.33
$1.25
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $120k 38,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.2k 38,000 shares
$1.98
$3.15
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $123k 98,501 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 27,700 shares
$1.59
$1.25
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $78.8k 25,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.3k 25,000 shares
$1.57
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $78.8k 25,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86k 50,000 shares
$1.72
$3.15
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $88.5k 70,801 shares
Last Trade
Mar 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67k 26,800 shares
$2.50
$1.25
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $63k 20,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 20,000 shares
$7.13
$3.15
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $55k 44,001 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$351k 44,001 shares
$7.98
$1.25
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $126k 40,000 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$596k 80,000 shares
$7.45
$3.15
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $92.8k 17,441 shares
Last Trade
Dec 04, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.92M 4,755 shares
$613.08
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $118k 22,196 shares
Last Trade
Dec 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.76M 8,333 shares
$931.68
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $73.8k 13,863 shares
Last Trade
Jul 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$34.3M 37,431 shares
$915.12
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $1.59M 299,444 shares
Last Trade
Jul 15, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.3M 37,431 shares
$915.12
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $273k 51,294 shares
Last Trade
Jul 15, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.3M 37,431 shares
$915.12
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $73.8k 13,863 shares
Last Trade
May 29, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.94M 2,496 shares
$776.52
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CFO & Chief Strategy Officer
Holding Value $87k 16,359 shares
Last Trade
May 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.39M 8,333 shares
$647.28
$5.32

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up